Yahoo Web Search

    • Recap: Sage Therapeutics Q2 Earnings

      Benzinga· 3 days ago

      Shares of Sage Therapeutics (NASDAQ:SAGE) were flat in pre-market trading after the company reported Q2 results. Earnings per share increased 36.59% over the past year to ($2.08), which beat ...